Try from €0.25 / day
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
PowderJect is to start clinical trials of a vaccine to combat hepatitis B as part of its continuing strategic alliance with GlaxoSmithKline.
Fri, 23 Feb, 2001
News
Monday, June 29, 2026 - 10:00 PM
Monday, June 29, 2026 - 6:00 PM